ArticlePharmaceutics2021

A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy.

Cristina Ioana Barbălată et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.